Skip to main content
. 2016 Jun 27;5(6):e238. doi: 10.1038/oncsis.2016.38

Figure 6.

Figure 6

Bifidobactreia suppress colonic inflammation and carcinogenesis in Ffar2−/− mice. (a) Ffar2−/− mice fed with FP diet and 1 month later were challenged with AOM/DSS and B. infantis as shown. B. infantis was gavaged everyday (2 × 108 cfu/mouse) as indicated from day of AOM injection till the completion of DSS treatment. (b) Relative abundance of Bifidobacterium in mice gavaged with B. infantis or saline as in a. Shown is the weight loss (c) during and after DSS challenge. (d) A representative photograph of H&E stained cross-section of colons of mice 4 days after cessation of DSS treatment. (e) Histopathological score (inflammation+epithelial damage) of colons. (f) Polyp burden in colons of mice treated as described in a at experimental endpoint. A representative of two experiments is shown (n=4 mice). *P<0.05, **P<0.01, ***P<0.0001.